Last reviewed · How we verify
Propofol half
At a glance
| Generic name | Propofol half |
|---|---|
| Also known as | 2.5% Propofol |
| Sponsor | China International Neuroscience Institution |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery (NA)
- Pilot Study on Pairing Sedation Strategies and Weaning (NA)
- Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management (PHASE2, PHASE3)
- ECT with Ketamine Anesthesia Vs High Intensity Ketamine with ECT Rescue for Treatment-Resistant Depression (PHASE4)
- Oropharyngeoesophageal Topical Anesthesia Versus Propofol - Ketamine Sedation for Upper Gastrointestinal Endoscopy (NA)
- Preanesthetic Analgesia/Nociception Index (ANI) and Propofol Injection Pain (NA)
- Sleep/Wake Protocol Implementation to Improve Sleep Quality in the ICU
- Dexmedetomidine vs Ketofol on Delirium in Children Undergoing Congenital Inguinal Hernia Repair (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |